Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Amgen Has US Rituximab Nod - But No RA Indication
Riabni Biosimilar Rival To Rituxan Seeks To Compete With Price Discount
Dec 18 2020
•
By
Dave Wallace
Amgen’s price discount matches that of Pfizer • Source: Shutterstock
More from Products
More from Generics Bulletin